eMedicine Specialties > Infectious Diseases > Bacterial Infections
HACEK Group Infections
Updated: Apr 13, 2009
Introduction
Background
The acronym HACEK refers to a grouping of gram-negative bacilli; Haemophilus species (Haemophilus parainfluenzae, Haemophilus aphrophilus, and Haemophilus paraphrophilus), Actinobacillus actinomycetemcomitans, Cardiobacterium hominis, Eikenella corrodens, and Kingella species. These organisms share an enhanced capacity to produce endocardial infections. They are responsible for 5-10% of cases of infective endocarditis (IE) involving native valves and are the most common cause of gram-negative endocarditis among persons who do not abuse intravenous drugs. All are part of the normal oropharyngeal flora, are slow growers, and prefer a carbon dioxide–enriched atmosphere. Because of their fastidious growth requirements, they have been a frequent cause of culture-negative endocarditis.
In addition to valvular infections, they also produce other infections such as bacteremias, various types of abscesses, peritonitis, otitis media, conjunctivitis, pneumonia, septic arthritis, osteomyelitis, urinary tract infections, wound infections, brain abscess, and periodontal infections. Because of its significance and challenging nature, both diagnostic and therapeutic, this review focuses on IE due to the HACEK group.
Pathophysiology
When introduced into healthy tissue, the HACEK group organisms have the potential for abscess formation and invasive disease. In addition, many examples produce luxuriant vegetations on infected cardiac valves that are complicated by macroemboli. These vegetations are due to the intrinsic properties of the organisms themselves, the significant delay in diagnosis, or to a combination of these 2 factors. Sixty percent of cases of HACEK IE are associated with various types of dental pathology.
Haemophilus species are pleomorphic gram-negative coccobacilli that require X (hemin) and/or V (nicotinamide adenine dinucleotide) factors for isolation. These substances are found naturally in red blood cells. They are responsible for 0.5-1% of all cases of IE. Of those, 40% are due to H aphrophilus, followed by H parainfluenzae. H influenzae rarely causes IE despite its frequency of being involved in bacteremias. Ten percent of cases involve a second pathogen, usually an alpha-hemolytic Streptococcus or Staphylococcus aureus. Endocarditis due to H parainfluenzae has been increasing in frequency. Of these cases, 45% are associated with oral pathology and 10% are associated with upper respiratory tract infections. In 67% of cases, the mitral valve is involved, and in 17%, the aortic valve is involved. Fifty percent of patients have underling valvular disease.
Thirty-three percent of cases of H aphrophilus IE are due to dental disease, and 20% are due to sinusitis or otitis media. The mitral valve is involved in 56% of patients, and the aortic valve is involved in 33%. Eighty-eight percent of individuals have underlying cardiac disease. Arterial embolization occurs in 31% of cases of IE caused by H aphrophilus.
A actinomycetemcomitans was first isolated in 1912 from skin lesions associated with Actinobacillus israelii. Growth of this bacillus occurs in trypticase soy broth, where it forms granules that float on top or stick to the container. It is the etiologic agent of localized juvenile periodontitis, one manifestation of early-onset periodontitis (EOP).
EOP includes a spectrum of entities in which severe periodontal attachment loss occurs in children, adolescents, and young adults. The ability of this organism to produce gingivitis is based in great part on its production of a leukotoxin and its ability to invade gingival cells. A actinomycetemcomitans, on its own, can mimic most of the clinical syndromes caused by A israelii. Of patients with IE caused by this pathogen, 86% have underlying heart disease and 25% have infection of a prosthetic valve (usually aortic). The aortic valve is involved in 65%, and the mitral valve is involved in 30%. Arterial embolization occurs in 43% of cases.
As opposed to the other members of the group, C hominis has been isolated almost exclusively from patients with endocarditis. In addition to being part of the normal flora of the mouth and upper airway, it is isolated from the large bowel. However, most bloodstream infections are secondary to oral pathology. They are gram-negative or gram-variable pleomorphic rods with bulbous swelling of both ends that are characteristically grouped in chains, clusters, or rosettes. Seventy-five percent of cases have underlying heart disease; 43% involving the mitral valve and 36% the aortic valve. Arterial embolization is documented in 40% of patients.
E corrodens takes its name from its ability to corrode (or pit) the agar during growth. It is a gram-negative pleomorphic, often coccobacillary, rod that exudes a chlorine bleach odor. It is facultatively anaerobic. It is part of the oral flora and many other mucosal surfaces.
E corrodens usually is isolated to other organisms, especially strains of streptococci. This organism is a well-recognized cause of cellulitis resulting from human bites and clenched-fist injuries. It also has been found to be a common cause of soft-tissue infections and endocarditis in drug users. This association may arise from the habit of intravenous drug abusers to lick their needles for good luck. These infections often are complicated by osteomyelitis of the underlying bones. It may produce a variety of pulmonary infections (eg, empyema, pneumonia, septic emboli) that mimic those caused by strict anaerobes. Most patients with endocarditis caused by this organism have underlying valve lesions. Compared to cases of IE caused by the other members of the HACEK group, the valvular infections of E corrodens usually are due to intravenous drug abuse.
Kingella species are small gram-negative organisms whose shapes range from those of cocci to those of coccobacilli. This organism also can cause pitting of the agar. The Kingella genus includes 3 species: Kingella kingae, Kingella denitrificans, and Kingella indologenes. IE usually is caused by K kingae. Only approximately 20 cases of endocarditis have been described. Unlike the other HACEK organisms, IE caused by this organism progresses quite rapidly.
Frequency
United States
In a study performed in 1982, the HACEK organisms were found to be responsible for 57% of endocarditis due to gram-negative organisms.1 This represents approximately 5-10% of native-valve endocarditis in patients who are not intravenous drug users. More recently, increased awareness of fastidious organisms by clinicians and microbiology laboratory personnel suggests these organisms probably are more frequently recognized today, although recent data are not available.
International
Although cases of endocarditis caused by the HACEK organisms have been reported in other countries, the precise incidence of infection with these organisms is not known.
Mortality/Morbidity
Endocarditis caused by the HACEK organisms characteristically develops on a subacute or chronic basis. At the time of presentation, valvular vegetations typically are larger than those resulting from more rapidly growing bacteria. Embolization is frequent and results in significant morbidity.
- Mortality rates range from 10-40% and are organism specific. The lowest mortality rate is observed in infections produced by H parainfluenzae. The rate observed with other examples usually ranges from 30-40%.
- Infectious endocarditis caused by Haemophilus species carries an arterial embolization rate of approximately 50%. That of other members of the group varies from 30-40%.
- Congestive heart failure (CHF) occurs in only 10% of cases of IE due to H parainfluenzae. Approximately 50% of patients with valvular infections due to the other examples of the HACEK group develop significant cardiac failure.
Race
- No racial differences have been reported in endocarditis caused by the HACEK organisms.
Sex
- In general, males develop HACEK endocarditis more often than females, except in the case of Haemophilus species, which favor middle-aged women.
Age
- The great majority of IE caused by HACEK organisms has been reported in older adults.
Clinical
History
IE produced by any of the HACEK organisms usually is of the subacute type. Rarely, this group may produce acute disease. Patients present with progressive symptoms developing over weeks. The mean time to diagnosis is approximately 3 months. Some cases have been present for as long as 18 months before the correct diagnosis is made. This delay often is due to difficulty in culturing the organisms (see Lab studies). HACEK IE should be considered in the differential diagnosis of fever of unknown origin.
- Fever is common but may be absent in elderly individuals, immunocompromised patients, or patients taking anti-inflammatory drugs. In some series, it was present in only 50% of cases.
- Nonspecific symptoms, such as weight loss, anorexia, nausea and vomiting, fatigue, back pain, and night sweats, are frequent and may lead to a delay in diagnosis.
- Most patients have had previously known valvular disease.
- A history of a dental procedure or recent oral pathology should be elicited.
- A history of intravenous drug abuse should be elicited.
- A sentinel headache may indicate the impending rupture of a mycotic aneurysm.
Physical
Given the difficulty of making the diagnosis early, performing a detailed physical examination is especially important. Special attention should be given to the heart, possible peripheral stigmata of IE (approximately 50% of patients, see Pathophysiology), CHF (up to 50% of patients), and possible embolic complications.
- Heart: A new or changing heart murmur is the most consistent physical finding, but it may be absent, especially in right-sided endocarditis.
- Peripheral/teguments
- Improvements in health care have contributed to earlier diagnosis and a reduction in the percentage of patients presenting with typical peripheral manifestations of subacute endocarditis.
- Examine the patient for clubbing (with or without hypertrophic osteoarthropathy), splinter hemorrhages, mucocutaneous petechiae, Osler nodes, Janeway lesions, and Roth spots.
- Splenomegaly is frequent.
- Embolic complications
- A vegetation can embolize to virtually any vessel. H parainfluenzae has the highest rate of embolization (60%).
- Observe for compromise of circulation to the limbs due to embolization.
- Emboli to the CNS often presents as a focal neurological deficit or a stroke. Emboli to the frontal lobe may be more subtle, causing personality changes or loss of inhibition.
- Emboli to the kidney may cause flank tenderness, hematuria, and/or oliguria.
- Listen for a rub after a splenic infarct.
- Embolization to heart vessels can present as a myocardial infarct with hypotension and arrhythmias. Most commonly, cardiac physical findings are due to valvular destruction.
- A large mesenteric embolus can cause bowel ischemia with secondary abdominal tenderness.
- Limbs may be affected by an occlusive thrombus. Watch for signs of hypoperfusion.
- A right-sided vegetation can metastasize to the lung and present similar to a pulmonary embolus or focal pneumonia.
Causes
- Patients often have a history of dental manipulation or poor oral hygiene.
- History of intravenous drug use also should be considered because many drug users clean their needles or venipuncture sites with saliva. Among the HACEK organisms, E corrodens is the bacterium that has been most frequently associated with intravenous drug abuse.
- Finally, as in other causes of infectious endocarditis, a history of abnormal native valves (eg, mitral valve prolapse) or prosthetic valves is a predisposing factor.
More on HACEK Group Infections |
Overview: HACEK Group Infections |
| Differential Diagnoses & Workup: HACEK Group Infections |
| Treatment & Medication: HACEK Group Infections |
| Follow-up: HACEK Group Infections |
| References |
| Next Page » |
References
Geraci JE, Wilson WR. Symposium on infective endocarditis. III. Endocarditis due to gram- negative bacteria. Report of 56 cases. Mayo Clin Proc. Mar 1982;57(3):145-8. [Medline].
Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA. Jun 11 1997;277(22):1794-801. [Medline].
Bayer AS, Bolger AF, Taubert KA, et al. Diagnosis and management of infective endocarditis and its complications. Circulation. Dec 22-29 1998;98(25):2936-48. [Medline].
Bayer AS, Scheld WM. Endocarditis and intravascular infections. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Disease. 5th ed. Philadelphia, Pa: Churchill Livingstone; 2000:857-902.
Berbari EF, Cockerill FR, Steckelberg JM. Infective endocarditis due to unusual or fastidious microorganisms. Mayo Clin Proc. Jun 1997;72(6):532-42. [Medline].
Goutzmanis JJ, Gonis G, Gilbert GL. Kingella kingae infection in children: ten cases and a review of the literature. Pediatr Infect Dis J. Sep 1991;10(9):677-83. [Medline].
Gustke CJ. A review of localized juvenile periodontitis (LJP): II. Clinical trials and treatment guidelines. Gen Dent. Nov-Dec 1998;46(6):580-7; quiz 588-9. [Medline].
Gustke CJ. A review of localized juvenile periodontitis (LJP): Part I. Clinical features, epidemiology, etiology, and pathogenesis. Gen Dent. Sep-Oct 1998;46(5):491-7. [Medline].
Hall G, Heimdahl A, Nord CE. Bacteremia after oral surgery and antibiotic prophylaxis for endocarditis. Clin Infect Dis. Jul 1999;29(1):1-8; quiz 9-10. [Medline].
Kugler KC, Biedenbach DJ, Jones RN. Determination of the antimicrobial activity of 29 clinically important compounds tested against fastidious HACEK group organisms. Diagn Microbiol Infect Dis. May 1999;34(1):73-6. [Medline].
Lampe AS, Schroijen MA, Smith SJ. [Endocarditis due to Aggregatibacter (formerly: Actinobacillus) actinomycetemcomitans, a bacterium that grows in characteristic star-shaped colonies]. Ned Tijdschr Geneeskd. Apr 5 2008;152(14):827-30. [Medline].
Mutters R. Actinobacillus, capnocytophaga, eikenella, kingella, and other fastidious or rarely encountered gram-negative rods. In: Murray PR, Tenover FC, Baron EJ, et al, eds. Manual of Clinical Microbiology. 7th ed. Washington, DC: ASM Press; 1999:561-71.
Parker SW, Apicella MA, Fuller CM. Hemophilus endocarditis. Two patients with complications. Arch Intern Med. Jan 1983;143(1):48-51. [Medline].
Pereira RM, Bucaretchi F, Tresoldi AT. Infective endocarditis due to Haemophilus aphrophilus: a case report. J Pediatr (Rio J). Mar-Apr 2008;84(2):178-80. [Medline].
Trexler Hessen M, Abrutyn E. Gram-Negative Bacterial Endocarditis. In: Kaye D, ed. Infective Endocarditis. 2nd ed. New York, NY: Raven Press; 1992:251-64.
Weinstein L, Brusch JL. Gram-Negative and Other Organisms. In: Weinstein L, Brusch JL, eds. Infective Endocarditis. New York, NY: Oxford University Press; 1996:73-122.
Westling K, Vondracek M. Actinobacillus (Aggregatibacter) actinomycetemcomitans (HACEK) identified by PCR/16S rRNA sequence analysis from the heart valve in a patient with blood culture negative endocarditis. Scand J Infect Dis. 2008;40(11-12):981-3. [Medline].
Wilson WR, Karchmer AW, Dajani AS, et al. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association. JAMA. Dec 6 1995;274(21):1706-13. [Medline].
Further Reading
Keywords
Haemophilus aphrophilus, Haemophilus paraphrophilus, Haemophilus parainfluenzae, Actinobacillus actinomycetemcomitans, Cardiobacterium hominis, Eikenella corrodens, Kingella species, endocarditis, gram-negative endocarditis
Overview: HACEK Group Infections